Titlebook: Hepatitis Prevention and Treatment; Joseph M. Colacino,Beverly A. Heinz Book 2004 Springer Basel AG 2004 Epidemiology.Hepatitis.Hepatitis

只看該作者 · 發(fā)表于 2025-3-28 16:09:12

Current standard of care in hepatitis C virus infection,progress in the management of chronic hepatitis C (CHC) in terms of achieving viral eradication and improving histology. Interferons (IFNs) were among the first agents used in the mid 1980s for the treatment of non-A, non-B hepatitis, a term then used to describe the yet-to-be identified HCV. Initia

只看該作者 · 發(fā)表于 2025-3-28 19:15:09

只看該作者 · 發(fā)表于 2025-3-29 01:35:18

Investigational Drugs in Clinical Development for the Treatment of Chronic Viral Hepatitis,~350 million people worldwide [1] with the majority of infections occurring in the developing world where preventive HBV vaccination has not been widely implemented. Chronic hepatitis C (CHC) affects~170 million people worldwide [2]. While extrahepatic disease due to these viruses does occur, the ch

只看該作者 · 發(fā)表于 2025-3-29 04:15:43

cal correlation is provided to stress the surgical and diagnostic importance of understanding the three-dimensional anatomic relationships of the orbit, the paranasal sinuses, and the nasolacrimal drainage system.

只看該作者 · 發(fā)表于 2025-3-29 08:45:44

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛(ài)論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 04:20
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved